Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Mizuho Initiates Coverage On Athira Pharma with Buy Rating, Announces Price Target of $6

Mizuho Initiates Coverage On Athira Pharma with Buy Rating, Announces Price Target of $6

Mizuho analyst Graig Suvannavejh initiates coverage on Athira Pharma (NASDAQ:ATHA) with a Buy rating and announces Price Target of $6.

July 7, 2022

1 minute read

Mizuho analyst Graig Suvannavejh initiates coverage on Athira Pharma (NASDAQ:ATHA) with a Buy rating and announces Price Target of $6.

GM Offers Tiny Convertible Electric Car in China

August 31, 6:49 AM

-Automotive News https://www.autonews.com/china/gm-offers-tiny-convertible-electric-car-china?utm_source=dlvr.it&utm_medium=twitter

January 13, 5:32 AM

Keybanc analyst Steve Barger maintains KLA (NASDAQ:KLAC) with a Overweight and raises the price target from $410 to $468.

May 24, 10:02 AM

Over the past 3 months, 10 analysts have published their opinion on Five Below (NASDAQ:FIVE) stock. These analysts…

November 7, 7:19 AM

United Microelectronics Corp (NYSE:UMC) reported net sales for October 2022. Sales for October grew 27.1% year-on-year to NT$24.34 billion. Sales…